Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 15,518 shares at $2.08 ($32K) on 2010-03-16, disclosed to the SEC on 2010-03-17.
Scheduled sale ($32k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 100 | $208 | 0.6% |
| 2 | $2.08 | 200 | $416 | 1.3% |
| 3 | $2.08 | 4,218 | $9K | 27.2% |
| 4 | $2.08 | 11,000 | $23K | 70.9% |
| Total | $2.08 avg | 15,518 | $32K | 100% |
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |